E114 - Do Psychiatric Drugs Work? (with Professor David Taylor)
Mar 7, 2025
auto_awesome
Join Professor David Taylor, a leading expert in psychopharmacology, as he dives into the effectiveness of antidepressants and the science behind their use. He unpacks common misconceptions about emotional numbing and withdrawal symptoms while advocating for evidence-based prescribing. The conversation touches on emerging treatments like ketamine and psilocybin, and new innovations for psychosis treatment. With insights drawn from over 375 clinical papers, Taylor emphasizes a personalized approach to mental health medication.
Antidepressants, while effective relative to placebo, are undergoing scrutiny regarding their efficacy, safety, and the validity of the chemical imbalance theory.
Regular assessments of antidepressant treatments are vital to evaluate effectiveness and manage withdrawal symptoms, which can be severe and varied.
Innovative treatments like psilocybin and ketamine are emerging as promising alternatives, requiring continued research to establish their long-term benefits.
Deep dives
Increasing Scrutiny of Antidepressants
Antidepressants are facing heightened scrutiny from both the public and medical professionals, raising questions about their efficacy and safety. This scrutiny includes doubts about the long-standing belief in a chemical imbalance as the cause of depression, with many clinicians now recognizing that depression is influenced by life experiences and genetic factors. While there are discussions regarding the validity of antidepressants, evidence from clinical trials indicates that they do have a positive impact relative to placebo. However, their effectiveness may be more limited than previously thought, necessitating a broader view of treatment options for depression.
The Importance of Regular Monitoring
It is essential for patients taking antidepressants to have regular assessments with their healthcare providers to evaluate the medication's effectiveness and any possible side effects. Many patients remain on these medications for years without proper follow-ups, leading to questions about whether the benefits outweigh the downsides. The clinical understanding is evolving to use antidepressants in a manner similar to antibiotics, as a targeted treatment for specific durations rather than continuous use. This method aims to ensure patients derive substantial benefits and minimize the risk of prolonged exposure to potential side effects.
Understanding Withdrawal Effects
Withdrawal effects from antidepressants can be more severe and varied than previously acknowledged, which significantly impacts patient experiences when discontinuing these medications. Personal experiences of withdrawal can include insomnia, mood fluctuations, and physical sensations such as dizziness or electric shocks. Understanding how to taper off antidepressants properly is crucial in mitigating withdrawal symptoms, and this can involve a much slower reduction in dosage than typically recommended. The recognition of these withdrawal symptoms adds complexity to assessing the long-term benefits and risks associated with long-term antidepressant use.
Emerging Treatments for Depression
Newer treatments for depression, such as psilocybin and ketamine, are showing promise as alternatives to traditional antidepressants due to their faster acting mechanisms and different modes of action. While these have demonstrated some effectiveness, ongoing research is necessary to determine their long-term advantages over existing treatments. The combination of biological interventions with psychological support may provide a dual approach to treating depression. The urgency for rapid relief from depressive symptoms underscores the importance of exploring innovative treatment options that can provide quicker results.
Advancements in Antipsychotic Medications
The development of new antipsychotic drugs, such as CAR-XT (or Cabenphi), represents a shift in exploring treatments that do not rely solely on dopamine antagonism. These medications offer new mechanisms of action, which could offer advantages for treatment-resistant psychosis while maintaining fewer side effects. The potential for CAR-XT to be more effective than existing antipsychotics is promising, although it requires further comparative studies for validation. This advancement highlights the evolving understanding of psychotic disorders and the necessity to explore diverse treatment modalities based on individual patient needs.
Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry.
Today we discuss:
- What the science says about the effectiveness of anti-depressants.
- Evidence based principles for prescribing anti-depressants safely.
- Common side effects and withdrawal symptoms.
- Do anti-depressants work via so called "emotional numbing" effects?
- The use of anti-depressants for other conditions such as OCD and PTSD.
- Emerging treatments for depression such as ketamine and psilocybin.
- New treatments for psychosis such as KarXT (Cobenfy).
Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.
If you would like to invite Alex to speak at your organisation please email alexcurmitherapy@gmail.com with "Speaking Enquiry" in the subject line.
Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - alexcurmitherapy@gmail.com with "Coaching" in the subject line.
Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
